Our analysis revealed that elevated METTL14 or METTL3 expression was significantly associated with inferior OS in JMML patients (p = 0.0249, Fig. 1B, and p = 0.0483, Fig. S1B, respectively). The gene discussed is METTL3; the disease is juvenile myelomonocytic leukemia.